ATC/DDD

ATC/DDD index J05AE

You are here: Home > ATC/DDD > J > J05 > J05A

- ATC/DDD
Anatomical therapeutic chemical (ATC) classification system
- J
ANTIINFECTIVES FOR SYSTEMIC USE
- J05
ANTIVIRALS FOR SYSTEMIC USE
- J05A
DIRECT ACTING ANTIVIRALS

J05AE

Protease inhibitors

ATC/DDD code J05AE for Protease inhibitors

The DDDs are based on combination therapy in HIV infections.

The DDDs for atazanavir and fosamprenavir are based on combination therapy with ritonavir as a pharmacokinetic enhancer.

The DDD for saquinavir is based on the dose recommendations for hard capsules.

J05AE01
Saquinavir
J05AE02
Indinavir
J05AE03
Ritonavir
J05AE04
Nelfinavir
J05AE05
Amprenavir
J05AE06
Lopinavir
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us